SK286253B6 - Parenterálna formulácia pozostávajúca z 10-hydroxy-10,11- tetrahydrokarbamazepínu, vody a glukózy, jej použitie, dávková jednotka a nádoba s jej obsahom - Google Patents

Parenterálna formulácia pozostávajúca z 10-hydroxy-10,11- tetrahydrokarbamazepínu, vody a glukózy, jej použitie, dávková jednotka a nádoba s jej obsahom Download PDF

Info

Publication number
SK286253B6
SK286253B6 SK505-2000A SK5052000A SK286253B6 SK 286253 B6 SK286253 B6 SK 286253B6 SK 5052000 A SK5052000 A SK 5052000A SK 286253 B6 SK286253 B6 SK 286253B6
Authority
SK
Slovakia
Prior art keywords
water
glucose
parenteral formulation
parenteral
compound
Prior art date
Application number
SK505-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK5052000A3 (en
Inventor
Hoogevest Peter Van
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK5052000A3 publication Critical patent/SK5052000A3/sk
Publication of SK286253B6 publication Critical patent/SK286253B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SK505-2000A 1997-10-09 1998-10-07 Parenterálna formulácia pozostávajúca z 10-hydroxy-10,11- tetrahydrokarbamazepínu, vody a glukózy, jej použitie, dávková jednotka a nádoba s jej obsahom SK286253B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721497.7A GB9721497D0 (en) 1997-10-09 1997-10-09 Organic compounds
PCT/EP1998/006382 WO1999018966A1 (en) 1997-10-09 1998-10-07 Parenteral formulations comprising carbamazepine or its derivatives

Publications (2)

Publication Number Publication Date
SK5052000A3 SK5052000A3 (en) 2000-12-11
SK286253B6 true SK286253B6 (sk) 2008-06-06

Family

ID=10820342

Family Applications (1)

Application Number Title Priority Date Filing Date
SK505-2000A SK286253B6 (sk) 1997-10-09 1998-10-07 Parenterálna formulácia pozostávajúca z 10-hydroxy-10,11- tetrahydrokarbamazepínu, vody a glukózy, jej použitie, dávková jednotka a nádoba s jej obsahom

Country Status (32)

Country Link
US (2) US6316417B1 (es)
EP (1) EP1033988B1 (es)
JP (2) JP2001519395A (es)
KR (1) KR100760326B1 (es)
CN (1) CN1210032C (es)
AR (1) AR015465A1 (es)
AT (1) ATE257383T1 (es)
AU (1) AU748034B2 (es)
BR (1) BR9812861A (es)
CA (1) CA2304661C (es)
CO (2) CO4950520A1 (es)
CZ (1) CZ298900B6 (es)
DE (1) DE69821024T2 (es)
DK (1) DK1033988T3 (es)
ES (1) ES2214738T3 (es)
GB (1) GB9721497D0 (es)
HK (1) HK1031824A1 (es)
HU (1) HU226106B1 (es)
ID (1) ID24134A (es)
IL (1) IL135123A0 (es)
MY (1) MY122129A (es)
NO (1) NO327263B1 (es)
NZ (1) NZ503526A (es)
PE (1) PE121998A1 (es)
PL (1) PL192287B1 (es)
PT (1) PT1033988E (es)
RU (1) RU2242231C2 (es)
SK (1) SK286253B6 (es)
TR (1) TR200000870T2 (es)
TW (1) TW584563B (es)
WO (1) WO1999018966A1 (es)
ZA (1) ZA989183B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US20100204178A1 (en) * 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
SI1928464T1 (sl) * 2005-09-30 2014-09-30 Lundbeck Inc. Nova parenteralna karbamazepinska formulacija
CA2635797C (en) * 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
US8372431B2 (en) * 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN101711739B (zh) * 2008-10-08 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 卡马西平的口服药物组合物
CN105726466A (zh) * 2014-12-10 2016-07-06 辽宁药联制药有限公司 一种奥卡西平注射剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2081965T3 (es) * 1989-12-27 1996-03-16 Ciba Geigy Ag Dispositivo para homogenizar la distribuccion no homogenea de la luz de un haz de rayos laser.
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
KR100760326B1 (ko) 2007-09-20
RU2242231C2 (ru) 2004-12-20
EP1033988A1 (en) 2000-09-13
KR20010072533A (ko) 2001-07-31
CA2304661C (en) 2007-12-11
AR015465A1 (es) 2001-05-02
BR9812861A (pt) 2000-08-08
GB9721497D0 (en) 1997-12-10
CN1210032C (zh) 2005-07-13
CO5090854A1 (es) 2001-10-30
CA2304661A1 (en) 1999-04-22
PL339446A1 (en) 2000-12-18
US6316417B1 (en) 2001-11-13
ZA989183B (en) 1999-04-09
US20020055503A1 (en) 2002-05-09
NO327263B1 (no) 2009-05-25
PT1033988E (pt) 2004-05-31
NO20001730L (no) 2000-04-04
TR200000870T2 (tr) 2000-10-23
ID24134A (id) 2000-07-06
CN1274286A (zh) 2000-11-22
NO20001730D0 (no) 2000-04-04
IL135123A0 (en) 2001-05-20
AU748034B2 (en) 2002-05-30
CZ20001279A3 (cs) 2000-07-12
ATE257383T1 (de) 2004-01-15
CZ298900B6 (cs) 2008-03-05
SK5052000A3 (en) 2000-12-11
PL192287B1 (pl) 2006-09-29
HUP0004362A3 (en) 2006-06-28
ES2214738T3 (es) 2004-09-16
DE69821024T2 (de) 2004-10-28
HU226106B1 (en) 2008-04-28
US6458770B1 (en) 2002-10-01
NZ503526A (en) 2003-01-31
DK1033988T3 (da) 2004-04-13
CO4950520A1 (es) 2000-09-01
HK1031824A1 (en) 2001-06-29
JP2001519395A (ja) 2001-10-23
PE121998A1 (es) 1999-12-08
DE69821024D1 (de) 2004-02-12
JP2005281314A (ja) 2005-10-13
TW584563B (en) 2004-04-21
WO1999018966A1 (en) 1999-04-22
EP1033988B1 (en) 2004-01-07
AU9629898A (en) 1999-05-03
MY122129A (en) 2006-03-31
HUP0004362A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
US11166923B2 (en) Parenteral dosage form of norepinephrine
US6310094B1 (en) Ready-to-use esmolol solution
EP3363428B1 (en) Perfusion dosage form
AU777619B2 (en) Suspension comprising oxcarbazepine
US20180028498A1 (en) A pharmaceutical composition for the parenteral administration of melatonin, and a process for its preparation
JP2005281314A (ja) カルバマゼピンまたはその誘導体を含む非経口製剤
HRP20020636A2 (en) Pharmaceutical composition comprising pemetrexed with monothioglycerol l-cystein or thioglycolic acid
MXPA00003413A (es) Formulaciones parenterales que comprenden carbamazepina o sus derivados
AU2004203644B2 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20091007